↓ Skip to main content

Dove Medical Press

Article Metrics

Risperidone-induced reversible neutropenia

Overview of attention for article published in Neuropsychiatric Disease and Treatment, July 2017
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
28 Mendeley
Title
Risperidone-induced reversible neutropenia
Published in
Neuropsychiatric Disease and Treatment, July 2017
DOI 10.2147/ndt.s141472
Pubmed ID
Authors

Vasanth Kattalai Kailasam, Victoria Chima, Uchechukwu Nnamdi, Kavita Sharma, Kairav Shah

Abstract

This case report presents a 44-year-old man with a history of schizophrenia who developed neutropenia on risperidone therapy. The patient's laboratory reports showed a gradual decline of leukocytes and neutrophils after resolution and rechallenging. This was reversed with the discontinuation of risperidone and by switching to olanzapine. In this case report, we also discuss the updated evidence base for management of risperidone-induced neutropenia.

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 21%
Student > Bachelor 4 14%
Student > Master 4 14%
Student > Postgraduate 3 11%
Researcher 2 7%
Other 5 18%
Unknown 4 14%
Readers by discipline Count As %
Medicine and Dentistry 6 21%
Psychology 3 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Arts and Humanities 2 7%
Immunology and Microbiology 2 7%
Other 4 14%
Unknown 9 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2017.
All research outputs
#12,842,970
of 14,537,474 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,024
of 2,487 outputs
Outputs of similar age
#229,157
of 268,405 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#83
of 91 outputs
Altmetric has tracked 14,537,474 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,487 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,405 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.